Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, and effect of TAP311 on blood lipids in
healthy subjects and in patients who have dyslipidemia. The effect of food on TAP311
concentration in blood and effect of TAP311 administration on simvastatin concentration will
also be assessed in healthy volunteers.